{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:07:54Z","timestamp":1784977674211,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00417-024-06605-8","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T19:45:31Z","timestamp":1724442331000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3802-3219","authenticated-orcid":false,"given":"Elham","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharat Chandra","family":"Vupparaboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Chandra","family":"Bollepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Kumar","family":"Vupparaboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"issue":"2","key":"6605_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106\u2013e116","journal-title":"Lancet Glob Health"},{"issue":"12","key":"6605_CR2","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","volume":"124","author":"JM Colijn","year":"2017","unstructured":"Colijn JM, Buitendijk GH, Prokofyeva E, Alves D, Cachulo ML, Khawaja AP et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753\u20131763","journal-title":"Ophthalmology"},{"issue":"3","key":"6605_CR3","doi-asserted-by":"publisher","first-page":"e0229694","DOI":"10.1371\/journal.pone.0229694","volume":"15","author":"A Shinojima","year":"2020","unstructured":"Shinojima A, Sawa M, Mori R, Sekiryu T, Oshima Y, Kato A et al (2020) Five-year follow-up of fundus autofluorescence and retinal sensitivity in the fellow eye in exudative age-related macular degeneration in Japan. PLoS ONE 15(3):e0229694","journal-title":"PLoS ONE"},{"issue":"4","key":"6605_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ophtha.2004.10.047","volume":"112","author":"TE Clemons","year":"2005","unstructured":"Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd (2005) Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112(4):533\u20139","journal-title":"Ophthalmology"},{"key":"6605_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","volume":"3","author":"KL Pennington","year":"2016","unstructured":"Pennington KL, DeAngelis MM (2016) Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 3:34","journal-title":"Eye Vis (Lond)"},{"issue":"3","key":"6605_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas CJ, Mirza RG, Gill MK (2021) Age-related macular degeneration. Med Clin North Am 105(3):473\u2013491","journal-title":"Med Clin North Am"},{"issue":"1","key":"6605_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/2474126416680671","volume":"1","author":"KG Csaky","year":"2017","unstructured":"Csaky KG, Schachat AP, Kaiser PK, Small KW, Heier JS (2017) The use of genetic testing in the management of patients with age-related macular degeneration: American Society of Retina Specialists Genetics Task Force Special Report. J VitreoRetinal Dis 1(1):75\u201378","journal-title":"J VitreoRetinal Dis"},{"issue":"3","key":"6605_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/eye.2011.335","volume":"26","author":"KN Amissah-Arthur","year":"2012","unstructured":"Amissah-Arthur KN, Panneerselvam S, Narendran N, Yang YC (2012) Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration. Eye 26(3):394\u2013399","journal-title":"Eye"},{"issue":"5","key":"6605_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10384-019-00680-9","volume":"63","author":"Y Sakurada","year":"2019","unstructured":"Sakurada Y, Sugiyama A, Kikushima W, Yoneyama S, Tanabe N, Matsubara M, Iijima H (2019) Pseudodrusen pattern and development of late age-related macular degeneration in the fellow eye of the unilateral case. Jpn J Ophthalmol 63(5):374\u2013381","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"6605_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaophthalmol.2018.2154","volume":"136","author":"Y Yanagi","year":"2018","unstructured":"Yanagi Y, Mohla A, Lee SY, Mathur R, Chan CM, Yeo I et al (2018) Incidence of fellow eye involvement in patients with unilateral exudative age-related macular degeneration. JAMA Ophthalmol 136(8):905\u2013911","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"6605_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamaophthalmol.2014.4252","volume":"133","author":"RE Gangnon","year":"2015","unstructured":"Gangnon RE, Lee KE, Klein BE, Iyengar SK, Sivakumaran TA, Klein R (2015) Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study. JAMA Ophthalmol 133(2):125\u2013132","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"6605_CR12","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1097\/IAE.0000000000000867","volume":"35","author":"NV Palejwala","year":"2015","unstructured":"Palejwala NV, Jia Y, Gao SS, Liu L, Flaxel CJ, Hwang TS et al (2015) Detection of non-exudative choroidal neovascularization in age-related macular degeneration with optical coherence tomography angiography. Retina (Philadelphia, Pa) 35(11):2204","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"6","key":"6605_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.ophtha.2016.01.044","volume":"123","author":"L Roisman","year":"2016","unstructured":"Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen C-L et al (2016) Optical coherence tomography angiography of asymptomatic neovascularization in intermediate age-related macular degeneration. Ophthalmology 123(6):1309\u20131319","journal-title":"Ophthalmology"},{"issue":"9","key":"6605_CR14","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1167\/iovs.16-21167","volume":"58","author":"Y Yanagi","year":"2017","unstructured":"Yanagi Y, Mohla A, Lee W-K, Lee SY, Mathur R, Chan CM et al (2017) Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 58(9):3488\u20133495","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"6605_CR15","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00417-018-4100-z","volume":"256","author":"T Bek","year":"2018","unstructured":"Bek T, Klug SE (2018) Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol 256(11):2061\u20132068","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"6605_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajo.2008.03.002","volume":"146","author":"T Ueta","year":"2008","unstructured":"Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R et al (2008) Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol 146(1):96-101. e2","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"6605_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oret.2018.08.003","volume":"3","author":"S Bochicchio","year":"2019","unstructured":"Bochicchio S, Xhepa A, Secondi R, Acquistapace A, Oldani M, Cigada MV et al (2019) The incidence of neovascularization in the fellow eye of patients with unilateral choroidal lesion: a survival analysis. Ophthalmol Retina 3(1):27\u201331","journal-title":"Ophthalmol Retina"},{"key":"6605_CR18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archopht.1993.01090090041018","volume":"111","author":"DB Burgess","year":"1993","unstructured":"Burgess DB, Jefferys JL (1993) Extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189\u20131199","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"6605_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ophtha.2013.11.031","volume":"121","author":"A Tufail","year":"2014","unstructured":"Tufail A, Xing W, Johnston R, Akerele T, McKibbin M, Downey L et al (2014) The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections. Ophthalmology 121(5):1092\u20131101","journal-title":"Ophthalmology"},{"issue":"10","key":"6605_CR20","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.ophtha.2014.04.026","volume":"121","author":"J Zarranz-Ventura","year":"2014","unstructured":"Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M et al (2014) The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology 121(10):1966\u20131975","journal-title":"Ophthalmology"},{"issue":"5","key":"6605_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/bjophthalmol-2019-314446","volume":"104","author":"K Fasler","year":"2020","unstructured":"Fasler K, Fu DJ, Moraes G, Wagner S, Gokhale E, Kortuem K et al (2020) Moorfields AMD database report 2: fellow eye involvement with neovascular age-related macular degeneration. Br J Ophthalmol 104(5):684\u2013690","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"6605_CR22","first-page":"87","volume":"35","author":"M Yuzawa","year":"1991","unstructured":"Yuzawa M, Hagita K, Egawa T, Minato H, Matsui M (1991) Macular lesions predisposing to senile disciform macular degeneration. Jpn J Ophthalmol 35(1):87\u201395","journal-title":"Jpn J Ophthalmol"},{"key":"6605_CR23","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1001\/archopht.1993.01090090041018","volume":"111","author":"D Burgess","year":"1993","unstructured":"Burgess D, Hawkins B, Jefferys J (1993) Macular Photocoagulation Study Group: five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189\u20131199","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"6605_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0161-6420(98)93025-1","volume":"105","author":"MA Sandberg","year":"1998","unstructured":"Sandberg MA, Weiner A, Miller S, Gaudio AR (1998) High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105(3):441\u2013447","journal-title":"Ophthalmology"},{"issue":"9","key":"6605_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1136\/bjo.84.9.1018","volume":"84","author":"M Uyama","year":"2000","unstructured":"Uyama M, Takahashi K, Ida N, Miyashiro M, Ando A, Takahashi A et al (2000) The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84(9):1018\u20131023","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"6605_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ophtha.2016.01.033","volume":"123","author":"RB Bhisitkul","year":"2016","unstructured":"Bhisitkul RB, Desai SJ, Boyer DS, Sadda SR, Zhang K (2016) Fellow eye comparisons for 7-year outcomes in ranibizumab-treated AMD subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study). Ophthalmology 123(6):1269\u20131277","journal-title":"Ophthalmology"},{"issue":"5","key":"6605_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ophtha.2004.11.040","volume":"112","author":"H Buch","year":"2005","unstructured":"Buch H, Nielsen NV, Vinding T, Jensen GB, Prause JU, la Cour M (2005) 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology 112(5):787\u2013798","journal-title":"Ophthalmology"},{"issue":"4","key":"6605_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1755-3768.2009.01566.x","volume":"88","author":"A Laitinen","year":"2010","unstructured":"Laitinen A, Laatikainen L, H\u00e4rk\u00e4nen T, Koskinen S, Reunanen A, Aromaa A (2010) Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88(4):463\u2013471","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"6605_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119(3):571\u2013580","journal-title":"Ophthalmology"},{"key":"6605_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G et al (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:1\u201313","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"6605_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0002-9394(02)01755-5","volume":"134","author":"KK Snow","year":"2002","unstructured":"Snow KK, Cote J, Yang W, Davis NJ, Seddon JM (2002) Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 134(6):842\u2013848","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"6605_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1442-9071.1997.tb01745.x","volume":"25","author":"W Smith","year":"1997","unstructured":"Smith W, Mitchell P, Wang J (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25(4):13\u201315","journal-title":"Aust N Z J Ophthalmol"},{"issue":"3","key":"6605_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00055735-200206000-00007","volume":"13","author":"L Hyman","year":"2002","unstructured":"Hyman L, Neborsky R (2002) Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 13(3):171\u2013175. https:\/\/doi.org\/10.1097\/00055735-200206000-00007","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"6605_CR34","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.ophtha.2015.06.053","volume":"122","author":"Y Kuroda","year":"2015","unstructured":"Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A et al (2015) Factors associated with recurrence of age-related macular degeneration after anti-vascular endothelial growth factor treatment: a retrospective cohort study. Ophthalmology 122(11):2303\u20132310","journal-title":"Ophthalmology"},{"key":"6605_CR35","first-page":"772","volume":"13","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Kamei M, Itabe H, Yoneda K, Bando H, Kume N, Tano Y (2007) Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis 13:772\u2013778","journal-title":"Mol Vis"},{"issue":"1","key":"6605_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","volume":"9","author":"Y Deng","year":"2022","unstructured":"Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L (2022) Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis 9(1):62\u201379","journal-title":"Genes Dis"},{"issue":"6","key":"6605_CR37","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1167\/iovs.10-6254","volume":"52","author":"M Pons","year":"2011","unstructured":"Pons M, Marin-Casta\u00f1o ME (2011) Nicotine increases the VEGF\/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci 52(6):3842\u20133853","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"6605_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ophtha.2006.09.022","volume":"114","author":"U Chakravarthy","year":"2007","unstructured":"Chakravarthy U, Augood C, Bentham GC, de Jong PTVM, Rahu M, Seland J et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114(6):1157\u20131163","journal-title":"Ophthalmology"},{"issue":"1","key":"6605_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dcan.2020.09.005","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang T, Mao S, Rappaport TS (2021) Directional neighbor discovery in mmWave wireless networks. Digit Commun Netw 7(1):1\u201315","journal-title":"Digit Commun Netw"},{"key":"6605_CR40","doi-asserted-by":"publisher","first-page":"156717","DOI":"10.1016\/j.scitotenv.2022.156717","volume":"840","author":"L Liu","year":"2022","unstructured":"Liu L, Li C, Yu H, Yang X (2022) A critical review on air pollutant exposure and age-related macular degeneration. Sci Total Environ 840:156717","journal-title":"Sci Total Environ"},{"issue":"3","key":"6605_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","volume":"113","author":"R Klein","year":"2006","unstructured":"Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, Liu K et al (2006) Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 113(3):373\u2013380","journal-title":"Ophthalmology"},{"issue":"2","key":"6605_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archophthalmol.2007.53","volume":"126","author":"SB Bressler","year":"2008","unstructured":"Bressler SB, Munoz B, Solomon SD, West SK, Team SEES (2008) Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. Arch Ophthalmol 126(2):241\u20135","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"6605_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/archopht.1995.01100060054032","volume":"113","author":"AP Schachat","year":"1995","unstructured":"Schachat AP, Hyman L, Leske MC, Connell A, Wu S-Y (1995) Features of age-related macular degeneration in a black population. Arch Ophthalmol 113(6):728\u2013735","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"6605_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","volume":"129","author":"R Klein","year":"2011","unstructured":"Klein R, Chou C-F, Klein BE, Zhang X, Meuer SM, Saaddine JB (2011) Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 129(1):75\u201380","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"6605_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ophtha.2005.08.012","volume":"113","author":"MC Leske","year":"2006","unstructured":"Leske MC, Wu S-Y, Hennis A, Nemesure B, Yang L, Hyman L et al (2006) Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology 113(1):29\u201335","journal-title":"Ophthalmology"},{"issue":"2","key":"6605_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajo.2011.02.004","volume":"152","author":"BL Vanderbeek","year":"2011","unstructured":"Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD (2011) Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am J Ophthalmol 152(2):273\u201382. e3","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"6605_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/07853890601097030","volume":"38","author":"GS Hageman","year":"2006","unstructured":"Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38(8):592\u2013604","journal-title":"Ann Med"},{"issue":"6","key":"6605_CR48","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajo.2010.01.007","volume":"149","author":"IA Barbazetto","year":"2010","unstructured":"Barbazetto IA, Saroj N, Shapiro H, Wong P, Ho AC, Freund KB (2010) Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol 149(6):939\u201346. e1","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6605_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/jop.2009.0126","volume":"26","author":"M-A Gamulescu","year":"2010","unstructured":"Gamulescu M-A, Helbig H (2010) Lack of therapeutic effect of ranibizumab in fellow eyes after intravitreal administration. J Ocul Pharmacol Ther 26(2):213\u2013216","journal-title":"J Ocul Pharmacol Ther"},{"key":"6605_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/CIA.S93820","volume":"11","author":"K Michalska-Ma\u0142ecka","year":"2016","unstructured":"Michalska-Ma\u0142ecka K, Kabiesz A, Kimsa MW, Strza\u0142ka-Mrozik B, Formi\u0144ska-Kapu\u015bcik M, Nita M, Mazurek U (2016) Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration. Clin Interv Aging 11:357\u201365","journal-title":"Clin Interv Aging"},{"issue":"7","key":"6605_CR51","doi-asserted-by":"publisher","first-page":"591","DOI":"10.47102\/annals-acadmedsg.V37N7p591","volume":"37","author":"Z Wu","year":"2008","unstructured":"Wu Z, Sadda SR (2008) Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singap 37(7):591","journal-title":"Ann Acad Med Singap"},{"issue":"6","key":"6605_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000228590","volume":"223","author":"A Rouvas","year":"2009","unstructured":"Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I, Vergados I (2009) The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica 223(6):383\u2013389","journal-title":"Ophthalmologica"},{"issue":"7","key":"6605_CR53","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1389200216666151001120831","volume":"16","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Morescalchi F, Duse S, Gambicorti E, Cancarini A, Costagliola C (2015) Pharmacokinetic and pharmacodynamic properties of anti-VEGF drugs after intravitreal injection. Curr Drug Metab 16(7):572\u2013584","journal-title":"Curr Drug Metab"},{"issue":"12","key":"6605_CR54","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","volume":"98","author":"RL Avery","year":"2014","unstructured":"Avery RL, Castellarin AA, Steinle NC, Dhoot DS, Pieramici DJ, See R et al (2014) Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98(12):1636\u20131641","journal-title":"Br J Ophthalmol"},{"issue":"98","key":"6605_CR55","first-page":"105","volume":"18","author":"C Zhang","year":"2014","unstructured":"Zhang C, Wang H, Nie J, Wang F (2014) Protective factors in diabetic retinopathy: focus on blood-retinal barrier. Discov Med 18(98):105\u2013112","journal-title":"Discov Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06605-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06605-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06605-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T06:36:33Z","timestamp":1738996593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06605-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["6605"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06605-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the University of Pittsburgh Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is a retrospective study involving patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"A \u201cwaiver of informed consent\u201d was obtained considering the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}}]}}